Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

2003/09/01 by Steven E. Raper, Steven E Raper, Narendra Chirmule +11 · 7 citations
Biochemistry, Genetics and Molecular Biology · #Cancer Research and Treatments #RNA Interference and Gene Delivery #Virus-based gene therapy research

paper · doi:10.1016/j.ymgme.2003.08.016

crossref issued 2003/09/01 · crossref published 2003/09/01 · crossref published-print 2003/09/01 · openalex publication_date 2003/09/01 · crossref created 2003/10/16 · crossref deposited 2020/03/26 · openalex created_date 2025/10/10 · crossref indexed 2026/07/18 · openalex updated_date 2026/08/01

Cited by

• The evolution of gene therapy in X-linked severe combined immunodeficiency
• Viral and nonviral delivery systems for gene delivery
• Genetic modification of somatic stem cells
• Gene Therapy for Cancer Treatment: Past, Present and Future
• The potential of oligonucleotides for therapeutic applications
• Gene therapy clinical trials worldwide to 2012 – an update
• Gene therapy [wikipedia]